Tech Company Financing Transactions
Flame Biosciences Funding Round
Flame Biosciences, based in New York, received $100 million from Rock Springs Capital, Acuta Capital and Adage Capital Management.
Transaction Overview
Company Name
Announced On
10/3/2020
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from this financing will be used to progress clinical trials and secure additional business development opportunities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Madison Ave. 1201
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Undisclosed
Website
Email Address
Overview
Flame Biosciences is a clinical stage company focused on the research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. Our company was founded around a pipeline of assets with best in class potential to make a positive impact on patients with cancer driven by inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harlan Weisman
Chief Operating Officer
David Barrett
VP - Bus. Development
Pamela Demain
Browse more venture capital transactions:
Prev: 10/3/2020: Dedrone venture capital transaction
Next: 10/3/2020: Iceye venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs